Resultats globals: 11 registres trobats en 0.02 segons.
Articles, 9 registres trobats
Documents de recerca, 2 registres trobats
Articles 9 registres trobats  
1.
14 p, 315.9 KB Traumatic events in dual disorders : prevalence and clinical characteristics / Blanco Presas, Laura (Benito Menni Complex Assistencial en Salut Mental) ; Sió, Albert (Benito Menni Complex Assistencial en Salut Mental) ; Hogg, Bridget (Parc de Salut Mar (Barcelona, Catalunya). Institut Hospital del Mar d'Investigacions Mèdiques) ; Esteve, Ricard (Parc de Salut Mar. Institut de Neuropsiquiatria i Addiccions) ; Radua, Joaquim (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Solanes, Aleix (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Gardoki-Souto, Itxaso (Parc de Salut Mar (Barcelona, Catalunya). Institut Hospital del Mar d'Investigacions Mèdiques) ; Sauras, Rosa (Parc de Salut Mar. Institut de Neuropsiquiatria i Addiccions) ; Farré, Adriana (Parc de Salut Mar. Institut de Neuropsiquiatria i Addiccions) ; Castillo, Claudio (Parc de Salut Mar. Institut de Neuropsiquiatria i Addiccions) ; Valiente-Gómez, Alicia (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal.) ; Pérez, Víctor (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal.) ; Torrens, Marta (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Amann, Benedikt L. (.Parc de Salut Mar. Institut Hospital del Mar d'Investigacions Mèdiques) ; Moreno-Alcázar, Ana (Parc de Salut Mar (Barcelona, Catalunya) Institut Hospital del Mar d'Investigacions Mèdiques) ; Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal
Psychological trauma has been identified in substance use disorders (SUD) as a major etiological risk factor. However, detailed and systematic data about the prevalence and types of psychological trauma in dual disorders have been scarce to date. [...]
2020 - 10.3390/jcm9082553
Journal of clinical medicine, Vol. 9 Núm. 8 (2020) , p. 2553  
2.
6 p, 285.2 KB Early developmental, temperamental and educational problems in 'substance use disorder' patients with and without ADHD. Does ADHD make a difference? / Skutle, Arvid (Bergen Clinics Foundation, Bergen, Norway) ; Bu, Eli Torild Hellandsjø (Bergen Clinics Foundation, Bergen, Norway) ; Jellestad, Finn Konow (Department of Biological and Medical Psychology, University of Bergen, Norway) ; van Emmerik-van Oortmerssen, Katelijne (The Netherlands Arkin, Amsterdam, The Netherlands) ; Dom, Geert (Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian Brothers, Boechout, Belgium) ; Verspreet, Sofie (Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian Brothers, Boechout, Belgium) ; Carpentier, Pieter Jan (Reinier van Arkel groep, 's-Hertogenbosch, The Netherlands) ; Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ; Franck, Johan (Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden) ; Konstenius, Maija (Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden) ; Kaye, Sharlene (National Drug and Alcohol Research Centre, UNSW Australia, Sydney, Australia) ; Demetrovics, Zsolt (Institute of Psychology, Eötvös Loránd University, Budapest, Hungary) ; Barta, Csaba (Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary) ; Fatséas, Melina (Laboratoire de psychiatrie Département d'addictologie, Université de Bordeaux, Bordeaux, France) ; Auriacombe, Marc (Laboratoire de psychiatrie Département d'addictologie, Université de Bordeaux, Bordeaux, France) ; Johnson, Brian (Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA) ; Faraone, Stephen V. (Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA) ; Levin, Frances R. (Columbia University/the New York State Psychiatric Institute, New York, USA) ; Allsop, Steve (National Drug Research Institute/Curtin University of Technology, Perth, Australia) ; Carruthers, Susan (National Drug Research Institute/Curtin University of Technology, Perth, Australia) ; Schoevers, Robert A. (Dept of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands) ; Koeter, Maarten W.J. (Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) ; van den Brink, Wim (Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) ; Moggi, Franz (University Hospital of Psychiatry, University of Bern, Bern, Switzerland) ; Møller, Merete (Sykehuset Østfold, Norway) ; van de Glind, Geurt (Trimbos Instituut, ICASA Foundation, The Netherlands) ; Universitat Autònoma de Barcelona
The prevalence of ADHD among patients with substance use disorder (SUD) is substantial. This study addressed the following research questions: Are early developmental, temperamental and educational problems overrepresented among SUD patients with ADHD compared to SUD patients without ADHD? Do this comorbid group receive early help for their ADHD, and are there signs of self-medicating with illicit central stimulants? An international, multi-centre cross-sectional study was carried out involving seven European countries, with 1205 patients in treatment for SUD. [...]
2015 - 10.1016/j.abrep.2015.03.001
Addictive Behaviors Reports, Vol. 2 (march 2015) , p. 13-18  
3.
7 p, 124.4 KB Dual Depression : A Sex Perspective / Farré, Adriana (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicinal Legal) ; Tirado-Muñoz, Judit (Institut Hospital del Mar d'Investigacions Mèdiques (Barcelona, Catalunya)) ; Torrens, Marta (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicinal Legal)
Mood and substance use disorders (SUDs) are mental conditions that are highly prevalent in the general population. Cooccurrence of major depression and SUD, also known as dual depression, is very common in the field of substance addiction. [...]
2017 - 10.1097/ADT.0000000000000118
Addictive Disorders & Their Treatment, Vol. 16 (august 2017) , p. 180-186  
4.
5 p, 121.6 KB Inhaled Loxapine for Agitation in Intoxicated Patients : A Case Series / Roncero, Carlos (Hospital Universitari Vall d'Hebron) ; Ros-Cucurull, Elena (Hospital Universitari Vall d'Hebron) ; Palma-Álvarez, Raúl Felipe (Hospital Universitari Vall d'Hebron) ; Abad, Alfonso Carlos (Hospital Universitari Vall d'Hebron) ; Fadeuilhe, Christian (Hospital Universitari Vall d'Hebron) ; Casas, Miquel (Hospital Universitari Vall d'Hebron) ; Grau-López, Lara (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Episodes of agitation are frequent in intoxicated patients who have a substance use disorder, a psychiatric disorder or both (dual diagnosis). For managing the agitation, it is necessary to act promptly in a safe environment and addressing any underlying etiology. [...]
2017 - 10.1097/WNF.0000000000000252
Clinical Neuropharmacology, Vol. 40 (october 2017) , p. 281-285  
5.
11 p, 963.4 KB Comparison of treatment outcomes in severe personality disorder patients with or without substance use disorders : a 36-month prospective pragmatic follow-up study / Lana, Fernando (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Sánchez-Gil, Carmen (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Adroher, Núria D (Institut Hospital del Mar d'Investigacions Mèdiques) ; Pérez, Víctor (Institut Hospital del Mar d'Investigacions Mèdiques) ; Feixas, Guillem (Department of Clinical Psychology and Psychobiology, Faculty of Psychology, University of Barcelona, Barcelona, Spain) ; Martí-Bonany, Josep (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Torrens, Marta (Institut Hospital del Mar d'Investigacions Mèdiques)
Concurrent personality disorder (PD) and substance use disorder (SUD) are common in clinical practice. However, SUD is the main criterion for study exclusion in most psychotherapeutic studies of PD. [...]
2016 - 10.2147/NDT.S106270
Neuropsychiatric Disease and Treatment, Vol. 12 (june 2016) , p. 1477-1487  
6.
20 p, 358.8 KB Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients : Results from an international multi-center study exploring DSM-IV and DSM-5 criteria / van de Glind, Geurt (Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) ; Konstenius, Maija (Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden) ; Koeter, Maarten W.J. (Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) ; van Emmerik-van Oortmerssen, Katelijne (Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands) ; Carpentier, Pieter-Jan (Reinier van Arkel groep, 's-Hertogenbosch, The Netherlands) ; Kaye, Sharlene (National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia) ; Degenhardt, Louisa (Melbourne School of Population and Global Health, University of Melbourne, Australia) ; Skutle, Arvid (Bergen Clinics Foundation, Bergen, Norway) ; Franck, Johan (Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden) ; Bu, Eli-Torild (Bergen Clinics Foundation, Bergen, Norway) ; Moggi, Franz (University Hospital of Psychiatry Bern and Department of Psychology, University of Fribourg, Fribourg, Switzerland) ; Dom, Geert (Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian Brothers, Boechout, Belgium) ; Verspreet, Sofie (Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian Brothers, Boechout, Belgium) ; Demetrovics, Zsolt (Institute of Psychology, Eötvös Loránd University, Budapest, Hungary) ; Kapitány-Fövény, Máté (Nyíro Gyula Hospital Drug Outpatient and Prevention Center, Budapest, Hungary) ; Fatséas, Melina (Laboratoire de psychiatrie, Sanpsy CNRS USR 3413, Université de Bordeaux, and Département d'addictologie, CH Ch. Perrens/CHU de Bordeaux, Bordeaux, France) ; Auriacombe, Marc (Laboratoire de psychiatrie, Sanpsy CNRS USR 3413, Université de Bordeaux, and Département d'addictologie, CH Ch. Perrens/CHU de Bordeaux, Bordeaux, France) ; Schillinger, Arild (Østfold Hospital Trust, Department for Substance Abuse Treatment, Norway) ; Møller, Merete (Østfold Hospital Trust, Department for Substance Abuse Treatment, Norway) ; Johnson, Brian (Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA) ; Faraone, Stephen V. (Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA) ; Ramos-Quiroga, J. Antoni (Hospital Universitari Vall d'Hebron) ; Casas, Miguel (Hospital Universitari Vall d'Hebron) ; Allsop, Steve (National Drug Research Institute/Curtin University of Technology, Perth, Australia) ; Carruthers, Susan (National Drug Research Institute/Curtin University of Technology, Perth, Australia) ; Schoevers, Robert A. (Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands) ; Wallhed, Sara (Stockholm Centre for Dependency Disorders, Sweden) ; Barta, Csaba (Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary) ; Alleman, Peter (Alcohol Treatment Research, Kirchlindach and Ellikon, Switzerland) ; Levin, Frances R. (Columbia University/New York State Psychiatric Institute, New York City, NY, USA) ; van den Brink, Wim (Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) ; Universitat Autònoma de Barcelona
Available studies vary in their estimated prevalence of attention deficit/hyperactivity disorder (ADHD) in substance use disorder (SUD) patients, ranging from 2 to 83%. A better understanding of the possible reasons for this variability and the effect of the change from DSM-IV to DSM-5 is needed. [...]
2013 - 10.1016/j.drugalcdep.2013.09.026
Drug and alcohol dependence, Vol. 134 (october 2013) , p. 158-166  
7.
10 p, 199.3 KB The relevance of personality traits in impulsivity-related disorders : from substance use disorders and gambling disorder to bulimia nervosa / Pino Gutiérrez, Amparo del (Universitat de Barcelona. Departament d'Infermeria de Salut Pública, Salut Mental i Maternoinfantil) ; Jiménez-Murcia, Susana (Hospital Universitari de Bellvitge (IBIDELL)) ; Fernández Aranda, Fernando (Hospital Universitari de Bellvitge) ; Agüera, Zaida (Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y Nutrición (CIBERobn)) ; Granero, Roser (Universitat Autònoma de Barcelona. Departament de Psicobiologia i de Metodologia de les Ciències de la Salut) ; Hakansson, Anders (Lunds universitet) ; Fagundo Morales, Ana Beatriz (Hospital de Bellvitge. Departament de Psiquiatria) ; Bolao, Ferran (Hospital Universitari de Bellvitge. Departament de Medicina Interna) ; Valdepérez, Ana (Institut d'Investigació Biomèdica Sant Pau) ; Mestre Bach, Gemma (Hospital de Bellvitge. Departament de Psiquiatria) ; Steward, Trevor (Hospital de Bellvitge. Departament de Psiquiatria) ; Penelo Werner, Eva (Universitat Autònoma de Barcelona. Departament de Psicobiologia i de Metodologia de les Ciències de la Salut) ; Moragas, Laura (Hospital de Bellvitge. Departament de Psiquiatria) ; Aymamí i Sanromà, Maria Neus (Hospital de Bellvitge. Departament de Psiquiatria) ; Gómez Peña, Mónica (Hospital de Bellvitge. Departament de Psiquiatria) ; Rigol Cuadra, Assumpta (Universitat de Barcelona. Departament d'Infermeria de Salut Pública, Salut Mental i Maternoinfantil) ; Martín Romera, Virginia (Universitat Autònoma de Barcelona. Departament de Psicobiologia i de Metodologia de les Ciències de la Salut) ; Menchón Magriñá, José Manuel (Hospital de Bellvitge. Departament de Psiquiatria) ; Universitat Autònoma de Barcelona
Background and aims. The main aim of this study was to analyze and describe the clinical characteristics and shared personality traits in different impulsivity-compulsivity spectrum disorders: substance use disorders (SUD), gambling disorder (GD), and bulimia nervosa (BN). [...]
2017 - 10.1556/2006.6.2017.051
Journal of Behavioral Addictions, 2017  
8.
7 p, 480.3 KB Stop&Go - Promoting healthy lifestyles during inpatient detoxification treatment : rationale, intervention design, methodology / Alcaraz Garcia, Saül (Universitat Autònoma de Barcelona. Grup d'Estudis de Psicologia de l'Esport (GEPE)) ; García-Barrachina, Marina (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Exercise could help in the treatment of substance addictions. However, there is a lack of programs promoting a healthy and physically active lifestyle for patients requiring inpatient detoxification treatment. [...]
El ejercicio puede ayudar a tratar las adicciones a sustancias. Sin embargo, se detecta una falta de programas que promuevan los estilos de vida activa y saludable para pacientes que requieran tratamiento de desintoxicación hospitalaria. [...]

2017
Revista de psicología del deporte, Vol. 26, Suplemento 4 (2017) , p. 81-87 (Congreso Mundial de Psicología del deporte)  
9.
6 p, 471.5 KB Patología dual: situación actual y retos de futuro / Torrens Melich, Marta (Hospital del Mar (Barcelona, Catalunya))
Se denomina "patología dual" a la concurrencia en un mismo individuo de, por lo menos, un trastorno por consumo de sustancias y otro trastorno psiquiátrico. Estos pacientes "duales" o con comorbilidad psiquiátrica, son frecuentes y presentan mayor gravedad tanto desde la perspectiva clínica como social que los sujetos que sólo presentan un tipo de trastorno (adictivo u otra enfermedad psiquiátrica). [...]
The term "dual diagnosis" refers to the co-occurrence of at least one substance use disorder with another psychiatric disorder in the same individual. These "dual" patients or patients with psychiatric comorbidity are common, and present greater severity from both the clinical and social perspectives than those subjects with only one type of disorder (addictive or other psychiatric illness). [...]

2008
Adicciones, Vol. 20, Núm. 4 (2008) , p. 315-320  

Documents de recerca 2 registres trobats  
1.
42 p, 549.1 KB El consum de substàncies dins de les Forces Armades / Folch Sallent, Laura ; Pardo Cladellas, Yolanda, dir. (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Universitat Autònoma de Barcelona. Facultat de Dret
Els motius de la realització d'aquest estudi són explorar i conèixer l'abús de substàncies dins d'aquest col·lectiu, ja que és un col·lectiu poc estudiat i del qual se'n té poca informació i coneixement. [...]
The main reason for the realization of this study is to explore and know the abuse of substances within this group, it is a group that is not sufficiently studied and which there is not enough information and knowledge. [...]

2018
Grau en Criminologia [805]  
2.
100 p, 3.1 MB Implementation of a group intervention to reduce intimate partner violence among women with substance use disorders / Tirado Muñoz, Judit ; Torrens Melich, Marta, dir. ; Gilchrist, Gail, dir. ; Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal
Antecedents: La violència de parella (VP) és un problema de salut pública mundial que repercuteix negativament en la salut física, psicològica, sexual i reproductiva de les dones. VP és més freqüent entre les dones amb trastorns per ús de substàncies (TUS) que entre les dones en població general, amb estudis que mostren una prevalença que oscil·la entre el 40% i el 70% entre les dones amb TUS en comparació amb una prevalença que oscil·la entre el 15% i el 40% entre les dones en població general en els països desenvolupats. [...]
Background: Intimate partner violence (IPV) is a global public health problem that impacts negatively on women's physical, psychological, sexual, and reproductive health. IPV is more prevalent among women with substance use disorders (SUD) than women in the general population, with studies reporting prevalence ranging from 40% to 70% among women with SUD compared to 15% to 40% among women in the general population in developed countries. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2015  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.